Research Paper Volume 14, Issue 4 pp 1959—1982
Comparison of one-week versus three-week paclitaxel for advanced pan-carcinomas: systematic review and meta-analysis
Figure 4. The forest plot of HR for PFS in the subgroup analysis based on the DDR of paclitaxel. HR: hazard ratio; PFS: progression-free survival; DDR: dose density ratio.